The University of Chicago Header Logo

Connection

James Liao to Endothelium, Vascular

This is a "connection" page, showing publications James Liao has written about Endothelium, Vascular.
Connection Strength

9.089
  1. Regulator of G-Protein Signaling 5 Maintains Brain Endothelial Cell Function in Focal Cerebral Ischemia. J Am Heart Assoc. 2020 09 15; 9(18):e017533.
    View in: PubMed
    Score: 0.640
  2. Linking endothelial dysfunction with endothelial cell activation. J Clin Invest. 2013 Feb; 123(2):540-1.
    View in: PubMed
    Score: 0.379
  3. Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury. Vasc Med. 2012 Dec; 17(6):379-85.
    View in: PubMed
    Score: 0.370
  4. Pleiotropic effects of statins. - Basic research and clinical perspectives -. Circ J. 2010 May; 74(5):818-26.
    View in: PubMed
    Score: 0.312
  5. Novel aspects of the roles of Rac1 GTPase in the cardiovascular system. Curr Opin Pharmacol. 2010 Apr; 10(2):116-21.
    View in: PubMed
    Score: 0.306
  6. Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event. Am J Cardiol. 2009 Feb 15; 103(4):437-41.
    View in: PubMed
    Score: 0.285
  7. Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1. Circ Res. 2008 Aug 15; 103(4):360-8.
    View in: PubMed
    Score: 0.276
  8. Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells. Am J Physiol Heart Circ Physiol. 2007 Apr; 292(4):H1937-42.
    View in: PubMed
    Score: 0.248
  9. Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res. 2007 Jan 05; 100(1):70-8.
    View in: PubMed
    Score: 0.247
  10. Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. J Clin Invest. 2006 Feb; 116(2):334-43.
    View in: PubMed
    Score: 0.233
  11. Rho GTPases, statins, and nitric oxide. Circ Res. 2005 Dec 09; 97(12):1232-5.
    View in: PubMed
    Score: 0.231
  12. Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells. Circulation. 2005 Jun 21; 111(24):3261-8.
    View in: PubMed
    Score: 0.223
  13. Essential role of endothelial Notch1 in angiogenesis. Circulation. 2005 Apr 12; 111(14):1826-32.
    View in: PubMed
    Score: 0.220
  14. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005; 45:89-118.
    View in: PubMed
    Score: 0.216
  15. Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol. 2003 May 01; 23(5):729-36.
    View in: PubMed
    Score: 0.190
  16. Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells. Arterioscler Thromb Vasc Biol. 2003 Feb 01; 23(2):198-203.
    View in: PubMed
    Score: 0.189
  17. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation. 2002 Jul 02; 106(1):57-62.
    View in: PubMed
    Score: 0.182
  18. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med. 2002 May; 8(5):473-9.
    View in: PubMed
    Score: 0.180
  19. Statins and ischemic stroke. Atheroscler Suppl. 2002 May; 3(1):21-5.
    View in: PubMed
    Score: 0.180
  20. Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation. 2002 Mar 19; 105(11):1368-73.
    View in: PubMed
    Score: 0.178
  21. Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem. 2001 May 11; 276(19):15983-9.
    View in: PubMed
    Score: 0.165
  22. Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-kappaB. Arterioscler Thromb Vasc Biol. 2001 Feb; 21(2):227-32.
    View in: PubMed
    Score: 0.165
  23. Direct vascular effects of HMG-CoA reductase inhibitors. Trends Cardiovasc Med. 2000 May; 10(4):143-8.
    View in: PubMed
    Score: 0.156
  24. A functional role of I kappa B-epsilon in endothelial cell activation. J Immunol. 2000 Mar 15; 164(6):3316-22.
    View in: PubMed
    Score: 0.155
  25. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 1999 Aug 20; 285(5431):1276-9.
    View in: PubMed
    Score: 0.149
  26. Activation of guanine nucleotide-binding proteins and induction of endothelial tissue-type plasminogen activator gene transcription by alcohol. J Biol Chem. 1999 Apr 23; 274(17):12055-60.
    View in: PubMed
    Score: 0.146
  27. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem. 1998 Sep 11; 273(37):24266-71.
    View in: PubMed
    Score: 0.140
  28. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol. 1998 Aug 15; 161(4):1970-6.
    View in: PubMed
    Score: 0.139
  29. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998 Mar 31; 97(12):1129-35.
    View in: PubMed
    Score: 0.135
  30. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem. 1997 Dec 12; 272(50):31725-9.
    View in: PubMed
    Score: 0.133
  31. Hydrogen peroxide-mediated transcriptional induction of macrophage colony-stimulating factor by TGF-beta1. J Immunol. 1997 Sep 01; 159(5):2418-23.
    View in: PubMed
    Score: 0.130
  32. Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J Clin Invest. 1995 Dec; 96(6):2661-6.
    View in: PubMed
    Score: 0.115
  33. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995 Jul; 96(1):60-8.
    View in: PubMed
    Score: 0.112
  34. Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein. J Clin Invest. 1995 Apr; 95(4):1457-63.
    View in: PubMed
    Score: 0.110
  35. Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism. Hypertension. 2015 Apr; 65(4):841-8.
    View in: PubMed
    Score: 0.109
  36. The G proteins of the G alpha i and G alpha q family couple the bradykinin receptor to the release of endothelium-derived relaxing factor. J Clin Invest. 1993 Nov; 92(5):2168-72.
    View in: PubMed
    Score: 0.100
  37. Specific receptor-guanine nucleotide binding protein interaction mediates the release of endothelium-derived relaxing factor. Circ Res. 1992 May; 70(5):1018-26.
    View in: PubMed
    Score: 0.090
  38. Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension. Clin Pharmacol Ther. 2012 Feb; 91(2):289-97.
    View in: PubMed
    Score: 0.088
  39. Rho-associated kinase activity, endothelial function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol. 2011 Oct; 31(10):2353-9.
    View in: PubMed
    Score: 0.085
  40. Increased leukocyte rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokers. Hypertens Res. 2010 Apr; 33(4):354-9.
    View in: PubMed
    Score: 0.077
  41. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation. 2009 Jan 06; 119(1):131-8.
    View in: PubMed
    Score: 0.071
  42. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):s39-42.
    View in: PubMed
    Score: 0.067
  43. Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease. Circ Res. 2006 Dec 08; 99(12):1426-32.
    View in: PubMed
    Score: 0.061
  44. Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms. J Cereb Blood Flow Metab. 2007 May; 27(5):998-1009.
    View in: PubMed
    Score: 0.061
  45. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol. 2005 Sep 05; 96(5A):24F-33F.
    View in: PubMed
    Score: 0.057
  46. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke. 2005 Oct; 36(10):2251-7.
    View in: PubMed
    Score: 0.057
  47. Induction of angiogenesis by heat shock protein 90 mediated by protein kinase Akt and endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2004 Dec; 24(12):2238-44.
    View in: PubMed
    Score: 0.053
  48. Statins: potent vascular anti-inflammatory agents. Int J Clin Pract Suppl. 2004 Oct; (143):41-8.
    View in: PubMed
    Score: 0.053
  49. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circ Res. 2004 Jul 23; 95(2):217-23.
    View in: PubMed
    Score: 0.052
  50. Statin therapy: having the good without the bad. Hypertension. 2004 Jun; 43(6):1171-2.
    View in: PubMed
    Score: 0.052
  51. 11,12-epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression. Bioorg Med Chem Lett. 2003 Nov 17; 13(22):4011-4.
    View in: PubMed
    Score: 0.050
  52. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol Cell Biol. 2003 Aug; 23(16):5726-37.
    View in: PubMed
    Score: 0.049
  53. Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol. 2002 Nov; 86(1):5-18.
    View in: PubMed
    Score: 0.047
  54. Inhibition of major histocompatibility complex class II gene transcription by nitric oxide and antioxidants. J Biol Chem. 2002 Jul 19; 277(29):26460-7.
    View in: PubMed
    Score: 0.045
  55. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol. 2001 Nov; 21(11):1712-9.
    View in: PubMed
    Score: 0.043
  56. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation. 2000 Dec 19; 102(25):3104-10.
    View in: PubMed
    Score: 0.041
  57. Targeting Rho in cardiovascular disease. Circ Res. 2000 Sep 29; 87(7):526-8.
    View in: PubMed
    Score: 0.040
  58. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 2000 Sep 28; 407(6803):538-41.
    View in: PubMed
    Score: 0.040
  59. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res. 2000 Jul 07; 87(1):19-25.
    View in: PubMed
    Score: 0.040
  60. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest. 2000 Jul; 106(1):15-24.
    View in: PubMed
    Score: 0.040
  61. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci. 1999 Jul; 40(8):1808-12.
    View in: PubMed
    Score: 0.037
  62. Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study. J Hypertens. 2019 05; 37(5):1083-1095.
    View in: PubMed
    Score: 0.036
  63. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem. 1999 Apr 23; 274(17):11924-9.
    View in: PubMed
    Score: 0.036
  64. [Regulation of endothelial NO production by Rho GTPase]. Med Klin (Munich). 1999 Apr 15; 94(4):211-8.
    View in: PubMed
    Score: 0.036
  65. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol. 1998 Jun; 63(6):732-9.
    View in: PubMed
    Score: 0.034
  66. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J Biol Chem. 1997 Dec 05; 272(49):30969-74.
    View in: PubMed
    Score: 0.033
  67. Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation. J Sex Med. 2013 Jun; 10(6):1502-15.
    View in: PubMed
    Score: 0.024
  68. Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis. Circ Res. 1991 Apr; 68(4):1027-34.
    View in: PubMed
    Score: 0.021
  69. Preservation of NO production by statins in the treatment of heart failure. Cardiovasc Res. 2003 Nov 01; 60(2):250-8.
    View in: PubMed
    Score: 0.012
  70. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest. 2002 Dec; 110(11):1729-38.
    View in: PubMed
    Score: 0.012
  71. [New findings on the action of HMG-CoA-reductase inhibitors]. Dtsch Med Wochenschr. 1997 Oct 10; 122(41):1255-9.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.